RapidAI (formerly iSchemaView Inc.)
About RapidAI (formerly iSchemaView Inc.)
RapidAI, formerly iSchemaView Inc., is a leading healthcare AI company that provides advanced imaging solutions and clinical decision support for physicians. Its platform is designed to enhance the diagnosis and management of life-threatening vascular and neurovascular conditions, primarily focusing on stroke, but also expanding into areas like pulmonary embolism and aortic disease. The AI-powered platform processes medical images, such as CT and MRI scans, to deliver accurate, real-time insights, enabling faster and more confident decision-making in critical care situations.
For physicians, RapidAI’s technology offers several key benefits. It automates image processing and analysis, providing easy-to-read, near real-time views of the brain and other vascular structures, which can significantly reduce the time to diagnosis and treatment. The platform integrates seamlessly into hospital workflows, often through PACS systems and mobile applications, facilitating improved collaboration among stroke teams, radiologists, and other specialists across multiple sites. This connectivity ensures that critical case information and AI outputs are accessible on the go, streamlining communication and resource allocation.
RapidAI’s solutions are clinically validated and FDA-cleared for various applications, including the detection of intracranial hemorrhages (ICH) and large vessel occlusions (LVO), and have been instrumental in expanding national stroke treatment guidelines. By providing standardized results and assisting less-experienced readers while reinforcing expert decisions, the technology helps ensure patients are triaged with appropriate treatment options, ultimately improving patient outcomes and operational efficiencies within health systems.
Focus Areas
Business Intelligence
| Key Investors | Lennertz & Co., Vista Credit Partners, Cullom Capital, Listwin Ventures |
| Partnerships | Health Holdings Company (Saudi Arabia), Baptist Health (Arkansas), Amazon Web Services (AWS), Penumbra, Alaska Stroke Coalition |
| Acquisitions | EndoVantage |
| Technology | Rapid Enterprise™ Platform, Deep Clinical AI, Rapid Edge Cloud (cloud-native with on-prem capabilities), AI operating system, Mobile App, Navigator Pro, Rapid Insights, Third-party integration (PACS, EMR) |
| FDA Clearances | 30+ cleared products (estimated) |
What Physicians Need to Know
For physicians, RapidAI's platform acts as an intelligent assistant, providing 'deep clinical AI' that goes beyond simple alerts to offer precise localization, characterization, quantification, and longitudinal tracking of disease. This significantly reduces cognitive burden, enhances diagnostic accuracy, and accelerates critical treatment decisions, especially in time-sensitive conditions like stroke and pulmonary embolism. The integrated workflow solutions and mobile access facilitate real-time collaboration and communication among care teams, leading to more efficient patient management and potentially improved outcomes. Leverage the detailed 3D visualizations and quantitative analysis for clearer understanding and patient education. Remember that while powerful, AI tools are meant to complement, not replace, your clinical judgment.
RapidAI is built for seamless integration within the healthcare ecosystem. Their Rapid Technology Partner Program and API enable integration with various technologies and systems, including PACS, RIS, EMR, worklists, and mobile communication platforms. Current partners include Allm, Ambra Health, Halo Communications, Mobile Heartbeat, Pulsara, Samsung Neurologica, Siemens Healthineers, Spok, and TigerConnect. The Rapid Edge Cloud platform is designed to connect intelligence, workflow, and teams across the health system, ensuring interoperability and flexibility to meet unique customer requirements.
What the Web Says
RapidAI, formerly iSchemaView Inc., is a healthcare technology company specializing in AI-driven imaging solutions for conditions like stroke, trauma, and vascular issues. Their platform analyzes brain scans to expedite diagnosis and treatment decisions, integrating with hospital systems and offering mobile app access. While the product is generally praised for its speed and accuracy in clinical settings, employee reviews indicate a mixed to negative sentiment regarding company culture and management.
Overall: MixedStrengths
- RapidAI's AI-driven platform significantly reduces the time needed for diagnosis and treatment decisions in stroke care.
- The software is highly accurate in detecting conditions like intracranial hemorrhage (ICH) and large vessel occlusion (LVO).
- The mobile app provides real-time notifications and access to results and patient images, improving care team coordination.
- The technology integrates well with existing hospital systems like PACS.
- Offers flexibility for remote work for some positions.
- The company offers competitive compensation and benefits, including 100% employee medical coverage and a home office stipend.
Limitations
- Several employee reviews highlight a toxic sales culture and micromanagement.
- There are concerns about the executive team, with reports of high turnover and mental abuse leading to medical leave for some employees.
- The mobile application has experienced glitches, including issues with notifications and logging in.
- The impact of RapidAI on some important clinical outcomes, such as patient harms, mortality, and quality of life, is uncertain due to limited evidence.
- The cost-effectiveness of RapidAI for stroke detection is currently unknown.
- Lack of transparency regarding the development methods of RapidAI's machine-learning models and potential for algorithmic bias.
Based on reviews from: Indeed.com, Elion, NCBI Bookshelf, Zippia, Slashdot, Reddit, Canadian Journal of Health Technologies, Canada's Drug Agency, RapidAI Website, Apple App Store, Working Nomads
Last updated: 2026-07-19
Videos
News, demos, and interviews about RapidAI (formerly iSchemaView Inc.).
Videos load interactively. If none appear, search YouTube for RapidAI (formerly iSchemaView Inc.) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]